BL
SGEN

Balentine LLC’s Seagen Inc. Common Stock SGEN Stock Holding History

Balentine LLC’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,819
Closed -$598K – 617
2023
Q3 		$598K Buy
2,819
+180
+7% +$36K 0.02% 232
2023
Q2 		$508K Buy
2,639
+1,143
+76% +$227K 0.02% 266
2023
Q1 		$303K Buy
+1,496
New +$240K 0.01% 410
2020
Q3 		– Sell
-150
Closed -$25K – 887
2020
Q2 		$25K Buy
150
+12
+9% +$1.79K ﹤0.01% 351
2020
Q1 		$16K Buy
+138
New +$15.3K ﹤0.01% 303

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Balentine LLC's SGEN Position: Q4 2023 in Review

Balentine LLC sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,819 shares — an estimated $598K sold.

Balentine LLC first reported a position in SGEN in Q1 2020 and held it in 5 quarters. The position peaked at $598K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Balentine LLC reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Balentine LLC sold 2,819 Seagen Inc. Common Stock shares in Q4 2023, an estimated $598K.
  • Balentine LLC first reported a position in Seagen Inc. Common Stock in Q1 2020 and held it in 5 quarters.
  • Balentine LLC's Seagen Inc. Common Stock position peaked at $598K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Balentine LLC's 13F filing for Q4 2023, filed 9 Feb 2024.